Peripheral Arterial Disease Trial, Recruiting
Who may be able to join
AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI
Who might be able to join this trial:
- People who have had Type 2 diabetes for more than 1 year
- People whose diabetes is classified as stage 3 or lower (confirm with trial site)
- People who are 18 years of age or older
- People who have ongoing, hard-to-treat nerve pain in their legs or feet related to diabetes, which has not responded well to treatment
- People whose ankle-brachial index (a test that compares blood pressure in the ankle and arm to check blood flow) result is below 0.9 (confirm with trial site)
Who may not be able to join:
- People who are currently taking blood-thinning medications (anticoagulants)
- People who currently have an active infection
- People whose HbA1c level (a measure of long-term blood sugar control) is above 10 (confirm with trial site)
- People who have a diagnosed psychiatric disorder or problems with memory or thinking
- People who currently use illegal drugs
- People who are currently receiving dialysis (a treatment that filters the blood when the kidneys cannot)
- People with a Body Mass Index (BMI) above 35
- People who have had surgery within the last 30 days
- People who have an open sore or ulcer on their legs or feet
- People who have calcium build-up in the arteries of their legs (confirm with trial site)
Important: Always verify eligibility with the trial site directly before applying.
Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.
Contact this trial
Principal Investigator: Magdalena Anitescu, MD, PhD, University of Chicago
Phone: (773) 834-5234
Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.
GP referral letter
Print a one-page summary to share with your doctor.
Trial details
Where this trial is recruiting
Primary endpoints
Improve vascular changes; Vascular improvement on lower extremities with the Ankle Brachial Index (ABI); Vascular improvement on lower extremities with the Toe Brachial Index (TBI); Vascular improvement on lower extremities with the Doppler Flowmetry
Can't join this trial?
Data last synced from ClinicalTrials.gov: 15 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.